BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 29873221)

  • 1. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps].
    Chen YJ; Chai XB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging biologics for the treatment of chronic rhinosinusitis.
    Pauwels B; Jonstam K; Bachert C
    Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.
    Kartush AG; Schumacher JK; Shah R; Patadia MO
    Am J Rhinol Allergy; 2019 Mar; 33(2):203-211. PubMed ID: 30587005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
    Bachert C; Gevaert P; Hellings P
    J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations.
    Li N; Peters AT
    Allergy Asthma Proc; 2015; 36(5):339-43. PubMed ID: 26314815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.
    Codispoti CD; Mahdavinia M
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):232-239. PubMed ID: 31295554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review.
    Rix I; Håkansson K; Larsen CG; Frendø M; von Buchwald C
    Am J Rhinol Allergy; 2015; 29(3):193-201. PubMed ID: 25975250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biologics in chronic rhinosinusitis: a systematic review.
    Iqbal IZ; Kao SS; Ooi EH
    Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
    Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
    Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on current evidence for biologics in chronic rhinosinusitis.
    Nasta MS; Chatzinakis VA; Georgalas CC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):18-24. PubMed ID: 31789925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis.
    Cai S; Xu S; Lou H; Zhang L
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1876-1886.e7. PubMed ID: 35272073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
    Lee M; Kim DW; Shin HW
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody therapy in sinonasal disease.
    Chiarella SE; Sy H; Peters AT
    Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.